Eugene Kennedy
Direttore Tecnico/Scientifico/R&S presso CARISMA THERAPEUTICS, INC.
Patrimonio netto: - $ in data 30/04/2024
Posizioni attive di Eugene Kennedy
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CARISMA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 02/05/2024 | - |
Storia della carriera di Eugene Kennedy
Precedenti posizioni note di Eugene Kennedy
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| GALERA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2022 | 01/09/2023 |
| LUMOS PHARMA, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2014 | 06/03/2021 |
| Thomas Jefferson University | Corporate Officer/Principal | 01/01/2006 | 01/12/2013 |
| Innovative Cellular Therapeutics, Inc. | Direttore Tecnico/Scientifico/R&S | - | - |
The Hope Funds for Cancer Research
 The Hope Funds for Cancer Research Miscellaneous Commercial ServicesCommercial Services The Hope Funds for Cancer Research provides funds for cancer research. The private company is based in Newport, RI. The company was founded by Leah Rush Cann. | Direttore/Membro del Consiglio | - | - |
| LUMOS PHARMA, INC. | Direttore Tecnico/Scientifico/R&S | 14/11/2017 | - |
Formazione di Eugene Kennedy
| University of Virginia | Undergraduate Degree |
| Medical College of Virginia | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 10 |
Posizioni
| Chief Tech/Sci/R&D Officer | 5 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| LUMOS PHARMA, INC. | Health Technology |
| GALERA THERAPEUTICS, INC. | Health Technology |
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
The Hope Funds for Cancer Research
The Hope Funds for Cancer Research Miscellaneous Commercial ServicesCommercial Services The Hope Funds for Cancer Research provides funds for cancer research. The private company is based in Newport, RI. The company was founded by Leah Rush Cann. | Commercial Services |
| Innovative Cellular Therapeutics, Inc. |
- Borsa valori
- Insiders
- Eugene Kennedy
- Esperienza
